Primary Care

Cancer Prevention

Questions discussed in this category

How do you counsel patients on semaglutide or tirzepatide in light of potential cancer risks?

Do you avoid using these agents only in patients with history of medullary thyroid cancer or pancreatic cancer? Are there other cancer risks we should...

1 Answer available

Is there safety data regarding the use of hormonal IUDs in patients with atypical ductal hyperplasia and other high risk, non-malignant breast lesions?

1 Answer available

How would you approach breast cancer screening in an adolescent patient with a CDH1 mutation?

1 Answer available

How do you approach a patient with discordant breast cancer risk prediction scores for prevention?

For example, if low GAIL and high Tyrer-Cuzick?

1 Answer available

For what patient groups (if any) do you routinely recommend screening colonoscopy prior to radiation for prostate cancer?

3 Answers available

Papers discussed in this category

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2013-01

Which risk model to use? Clinical implications of the ACS MRI screening guidelines.

AJR Am J Roentgenol, 2021 May 12

Distribution of Estimated Lifetime Breast Cancer Risk Among Women Undergoing Screening Mammography.

Cancer Prev Res (Phila), 2013 Aug 20

Assessing the breast cancer risk distribution for women undergoing screening in British Columbia.

Breast Cancer Res Treat, 2011 Oct 22

A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance.

BMC endocrine disorders, 2024 Nov 18

Risk of Hepatocellular Carcinoma with Glucagon-like Peptide-1 receptor agonist treatment in patients: a systematic review and meta-analysis.

International urology and nephrology, 2024 Nov 04

Effect of GLP-1 receptor agonists on prostate cancer risk reduction: a systematic review and meta-analysis.

Cancers, 2024 Sep 22